Target intelligence / Profile preview

Rho GTPase activating protein 5 pseudogene

Molecular classification
Pseudogene
01

Overview

Rho GTPase activating protein 5 pseudogene (ENSG00000218586) is a genomic sequence related to the protein-coding ARHGAP5 gene but does not produce a functional protein product. Pseudogenes are generally non-coding DNA remnants, sometimes transcribed as RNA, and may play regulatory roles by acting as competing endogenous RNAs (ceRNAs) to sequester microRNAs and thereby influence the expression of their parent genes. While ARHGAP5 is a known regulator of Rho GTPase signaling and cytoskeletal dynamics, the pseudogene itself is not directly involved in these functions[1][4][7]. Current evidence on similar pseudogenes suggests possible involvement in cancer regulatory circuitry, but this is not specific to the ARHGAP5 pseudogene itself and requires further research[7]. The pseudogene is *not* considered a therapeutic target, receptor, enzyme, nor is it involved in direct signal transduction.

Other names
ARHGAP5PRho GTPase-activating protein 5 pseudogeneARHGAP5 pseudogeneARHGAP5P1
02

Biological functions

May act as a competing endogenous RNA (ceRNA) that regulates the expression of its parent gene by sequestering microRNAs (inferred by analogy to other RhoGAP pseudogenes such as RACGAP1P)No direct catalytic or signaling function; does not encode a protein
03

Disease associations

Potential regulator in cancer progression if acting through ceRNA mechanisms, as shown for related RhoGAP family pseudogenesNo direct or primary association with disease as a protein or target

Beyond the preview

Go deeper on Rho GTPase activating protein 5 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rho GTPase activating protein 5 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call